MAFM
TAK icon

Mid Atlantic Financial Management’s Takeda Pharmaceutical TAK Stock Holding History

Mid Atlantic Financial Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,569
Closed -$192K – 900
2020
Q4 		$192K Buy
+10,569
New +$185K 0.01% 729
2020
Q2 		– Sell
-10,105
Closed -$153K – 777
2020
Q1 		$153K Buy
+10,105
New +$183K 0.02% 594

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mid Atlantic Financial Management's TAK Position: Q1 2021 in Review

Mid Atlantic Financial Management sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 10,569 shares — an estimated $192K sold.

Mid Atlantic Financial Management first reported a position in TAK in Q1 2020 and held it in 2 quarters. The position peaked at $192K in Q4 2020. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

  • Mid Atlantic Financial Management reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Mid Atlantic Financial Management sold 10,569 Takeda Pharmaceutical shares in Q1 2021, an estimated $192K.
  • Mid Atlantic Financial Management first reported a position in Takeda Pharmaceutical in Q1 2020 and held it in 2 quarters.
  • Mid Atlantic Financial Management's Takeda Pharmaceutical position peaked at $192K in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q1 2021, filed 11 May 2021.